Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Hereditary haemochromatosis

View through CrossRef
Abstract Hereditary haemochromatosis syndromes are inherited disorders whereby inappropriate absorption of iron by the small intestine leads to iron deposition in the viscera, endocrine organs, and other sites, causing structural injury and impaired function. The most common form is classical adult (HFE-related) haemochromatosis, but other forms are recognized. Extended genetic platforms are increasingly used for specific diagnosis and noninvasive methods are increasingly used to evaluate hepatic damage. The mainstay of treatment is venesection although iron chelation therapy is an emerging oral alternative. Unravelling the molecular genetics of haemochromatosis is underpinning promising new therapies for disorders of iron homeostasis. Classical adult (HFE-related) haemochromatosis: aetiology and pathogenesis—inherited as a recessive trait and due to mutations in the major histocompatibility complex class I-related HFE gene that appear to reduce liver production of hepcidin. The principal mutant allele of HFE, designated C282Y, is carried by approximately 1 in 10 individuals of European ancestry, hence around 1 in 200 are homozygotes, usually with biochemical abnormalities of iron storage that may lead to full-blown clinical haemochromatosis. Clinical features—expression of disease may range from slight abnormalities of blood parameters that reflect iron metabolism to the established clinical syndrome of cutaneous pigmentation, cardiomyopathy, endocrine failure (especially diabetes mellitus and hypogonadism), arthritis, and pigment cirrhosis. Diagnosis—usually established by demonstrating abnormalities of iron metabolism. Molecular analysis of the HFE gene, in particular for homozygosity for the C282Y allele, is confirmatory. Management and prognosis—this is directed to the removal of iron by phlebotomy until the serum ferritin concentration is reduced to within the low normal range, after which the frequency of phlebotomy is reduced. Family members—first-degree relatives should be offered screening.
Title: Hereditary haemochromatosis
Description:
Abstract Hereditary haemochromatosis syndromes are inherited disorders whereby inappropriate absorption of iron by the small intestine leads to iron deposition in the viscera, endocrine organs, and other sites, causing structural injury and impaired function.
The most common form is classical adult (HFE-related) haemochromatosis, but other forms are recognized.
Extended genetic platforms are increasingly used for specific diagnosis and noninvasive methods are increasingly used to evaluate hepatic damage.
The mainstay of treatment is venesection although iron chelation therapy is an emerging oral alternative.
Unravelling the molecular genetics of haemochromatosis is underpinning promising new therapies for disorders of iron homeostasis.
Classical adult (HFE-related) haemochromatosis: aetiology and pathogenesis—inherited as a recessive trait and due to mutations in the major histocompatibility complex class I-related HFE gene that appear to reduce liver production of hepcidin.
The principal mutant allele of HFE, designated C282Y, is carried by approximately 1 in 10 individuals of European ancestry, hence around 1 in 200 are homozygotes, usually with biochemical abnormalities of iron storage that may lead to full-blown clinical haemochromatosis.
Clinical features—expression of disease may range from slight abnormalities of blood parameters that reflect iron metabolism to the established clinical syndrome of cutaneous pigmentation, cardiomyopathy, endocrine failure (especially diabetes mellitus and hypogonadism), arthritis, and pigment cirrhosis.
Diagnosis—usually established by demonstrating abnormalities of iron metabolism.
Molecular analysis of the HFE gene, in particular for homozygosity for the C282Y allele, is confirmatory.
Management and prognosis—this is directed to the removal of iron by phlebotomy until the serum ferritin concentration is reduced to within the low normal range, after which the frequency of phlebotomy is reduced.
Family members—first-degree relatives should be offered screening.

Related Results

Primary Hereditary Haemochromatosis and Pregnancy
Primary Hereditary Haemochromatosis and Pregnancy
Background. Haemochromatosis is a rare autosomal genetic disease that can cause multiple organ failure. In the past, this condition was not considered to affect pregnancy. The obje...
Hereditary haemochromatosis beyond liver cancer: increased risk of prostate cancer during an 11-year follow-up
Hereditary haemochromatosis beyond liver cancer: increased risk of prostate cancer during an 11-year follow-up
AbstractIn European ancestry populations, the iron overload disorder Hereditary Haemochromatosis (HH) is predominantly caused by the HFE p.C282Y mutation. Male p.C282Y homozygotes ...
HFE mutations in patients with hereditary haemochromatosis in Sweden
HFE mutations in patients with hereditary haemochromatosis in Sweden
Cardoso EMP, Stål P, Hagen K, Cabeda JM, Esin S, De Sousa M, Hultcrantz R (Karolinska Hospital, Stockholm; Huddinge University Hospital, Huddinge; and Karolinska Institute, Stockho...
Association of Familial Pernicious Anaemia and Hereditary Haemochromatosis
Association of Familial Pernicious Anaemia and Hereditary Haemochromatosis
We report the case of a 54-year-old patient presenting with a typical pernicious anaemia. His mother was diagnosed with unquestionable pernicious anaemia 5 years previously. Serum ...
Exploring metabolic dysregulation and therapeutic targets in sickle cell disease and rare hereditary red blood cell disorders
Exploring metabolic dysregulation and therapeutic targets in sickle cell disease and rare hereditary red blood cell disorders
Hereditary red blood cell (RBC) disorders are genetically and phenotypically heterogenous disorders that may all impact RBC metabolism to a variable extent. Hereditary hemolytic an...
Exocrine pancreatic insufficiency and idiopathic haemochromatosis
Exocrine pancreatic insufficiency and idiopathic haemochromatosis
SummaryThe case history of a 34-year-old patient with precirrhotic idiopathic haemochromatosis and severe chronic steatorrhoea is presented. The pancreas had a normal appearance on...
Adrenocortical function in idiopathic haemochromatosis
Adrenocortical function in idiopathic haemochromatosis
Abstract. In idiopathic haemochromatosis, excessive iron deposits include adrenal cortex, and mainly the zona glomerulosa. In this view, we measured basal and poststimulative value...

Back to Top